Table 1 Demographic and clinical characteristics of MESA participants by groups of eGFRcys, 2000-2002
| Â | eGFRcys <60 (n = 376) | eGFRcys 60-90 (n = 2746) | eGFRcys >90 (n = 3629) | P Value* |
|---|---|---|---|---|
Age, years†| 71 ± 9 | 66 ± 10 | 59 ± 9 | <0.001 |
Female, n(%) | 185 (49) | 1131 (48) | 2066 (57) | <0.001 |
Race/Ethnicity, n(%) | Â | Â | Â | <0.001 |
   Caucasian | 165 (44) | 1151 (42) | 1286 (35) |  |
   African-American | 103 (27) | 715 (26) | 1048 (29) |  |
   Hispanic | 72 (19) | 617 (23) | 795 (22) |  |
   Chinese-American | 36 (10) | 263 (10) | 500 (14) |  |
Current Smoker, n(%) | 50 (13) | 386 (14) | 440 (12) | 0.08 |
Current Alcohol Use, n(%) | 169 (45) | 1457 (53) | 2087 (58) | <0.001 |
BMI, kg/m2 | 30 ± 6 | 29 ± 6 | 28 ± 5 |  |
Prevalent Diabetes, n(%) | 94 (25) | 401 (15) | 464 (13) | <0.001 |
Prevalent Hypertension, n(%) | 272 (72) | 1451 (53) | 1310 (36) | <0.001 |
ACE Inhibitor Use, n(%) | 113 (30) | 501 (18) | 410 (11) | <0.001 |
Statin Use, n(%) | 77 (21) | 465 (17) | 459 (13) | <0.001 |
Fasting Plasma Glucose, mg/dl | 111 ± 34 | 105 ± 29 | 104 ± 32 | <0.001 |
Triglycerides, mg/dl§ | 131 (93, 180) | 126 (88, 179) | 107 (77, 157) | <0.001 |
HDL Cholesterol, mg/dl | 47 ±14 | 49 ± 14 | 53 ±15 | <0.001 |
LDL Cholesterol, mg/dl | 114 ± 35 | 116 ± 6 | 118 ± 31 | 0.01 |
Urinary Creatinine, mg/dl‡ | 96 (65, 142) | 111 (66, 163) | 106 (55, 162) | 0.001 |
Urine Albumin/Creatinine, mg/g | 10 (5, 47) | 6 (3, 12) | 5 (3, 10) | <0.001 |
Serum Creatinine, mg/dl | 1.4 ± 0.8 | 1.0 ± 0.2 | 0.9 ± 0.2 | <0.001 |
eGFR Creatinine, ml/min/1.73 m2 | 52 ± 17 | 73 ± 14 | 87 ± 14 | <0.001 |
eGFR Cystatin, ml/min/1.73 m2 | 50 ± 10 | 78 ± 8 | 108 ± 15 | <0.001 |